1 – 38 of 38
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
(
- Contribution to journal › Article
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
(
- Contribution to journal › Article
-
Mark
Somatic late effects in 5-year survivors of neuroblastoma : a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia study
(
- Contribution to journal › Article
-
Mark
Neuroblastoma with flat genomic profile : A question of representativity?
(
- Contribution to journal › Article
-
Mark
High risk of hypogonadism in young male cancer survivors
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus Syndrome
(
- Contribution to journal › Article
- 2017
-
Mark
Venous thrombosis in children and adolescents with Hodgkin lymphoma in Sweden
(
- Contribution to journal › Article
-
Mark
Predominance of girls with cancer in families with multiple childhood cancer cases
(
- Contribution to journal › Article
- 2016
-
Mark
Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis.
(
- Contribution to journal › Article
-
Mark
Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma
(
- Contribution to journal › Article
-
Mark
Reliability of AMH in Serum after Long-term Storage at -80°C and an Extended Thawing Episode
(
- Contribution to journal › Article
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article
- 2015
-
Mark
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
(
- Contribution to journal › Article
-
Mark
Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
(
- Contribution to journal › Article
-
Mark
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
(
- Contribution to journal › Article
-
Mark
Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.
(
- Contribution to journal › Article
-
Mark
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.
(
- Contribution to journal › Article
- 2014
-
Mark
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study.
(
- Contribution to journal › Article
-
Mark
Emergence of New ALK Mutations at Relapse of Neuroblastoma.
(
- Contribution to journal › Article
-
Mark
A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
(
- Contribution to journal › Article
- 2013
-
Mark
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.
(
- Contribution to journal › Article
-
Mark
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
(
- Contribution to journal › Article
-
Mark
Absence of Epstein-Barr and Cytomegalovirus Infection in Neuroblastoma Cells by Standard Detection Methodologies.
(
- Contribution to journal › Article
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
-
Mark
Acute onset of ovarian dysfunction in young females after start of cancer treatment.
(
- Contribution to journal › Article
- 2012
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma
(
- Contribution to journal › Article
-
Mark
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
(
- Contribution to journal › Article
-
Mark
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
(
- Contribution to journal › Article
-
Mark
Tumor-initiating cells in childhood neuroblastoma : Letter
(
- Contribution to journal › Letter
- 2011
-
Mark
Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research.
(
- Contribution to journal › Article
-
Mark
Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas.
(
- Contribution to journal › Article
- 2010
-
Mark
Deletions of 16q in Wilms Tumors Localize to Blastemal-Anaplastic Cells and Are Associated with Reduced Expression of the IRXB Renal Tubulogenesis Gene Cluster.
(
- Contribution to journal › Article
-
Mark
Young age at diagnosis is a risk factor for negative late socio-economic effects after acute lymphoblastic leukemia in childhood.
(
- Contribution to journal › Article
-
Mark
Generation of trisomies in cancer cells by multipolar mitosis and incomplete cytokinesis.
(
- Contribution to journal › Article
-
Mark
Genetic bottlenecks and the hazardous game of population reduction in cell line based research.
(
- Contribution to journal › Article